Evidence Based This post has 42 references

The Bliss Gene: FAAH SNPs (rs324420)

Written by Joe Cohen, BS | Last updated:

FAAH Intro

Fatty acid amide hydrolase or FAAH metabolizes anandamide to Arachidonic acid. Anandamide is our natural cannabinoid bliss molecule.

Anandamide will activate the cannabinoid/CB1 receptor and interact with CB1 receptor SNPs.

The endocannabinoid system got its name from cannabis since THC is closely related to the brain’s own anandamide.

Anandamide is taken from the Sanskrit word ananda, meaning bliss – because when it binds to the cannabinoid receptor, it has a calming effect.

Genetic deletion of FAAH in animal studies produces antidepressant-like effects, and this is thought to be mediated by increased serotonin and noradrenaline transmission [1].

Mice completely lacking FAAH experience less pain, seizures, and less motility [2].

We will generally want more anandamide and less arachidonic acid. Therefore, having lower FAAH enzyme activity can have some good effects.

Anandamide enhances levels of adenosine outside of cells and induces sleep [3].

FAAH is found in the brain, small intestine, pancreas and muscle [4].


C is the more common allele. Only 26% of the alleles in the global population are “A”.

I’m rs324420 AC.


A=lower FAAH.

AA=high anandamide, 5X higher risk for substance abuse, does better with lower fat, more Slow-wave sleep, lower risk of PTSD (fear extinction in the amygdala) and less awake after 10mg amphetamines (but not 20mg).


C encodes the more common Proline, while the A allele encodes the Threonine [5].

The change displays normal enzyme properties but an enhanced sensitivity to degradation [5].

Functional in-vitro studies further revealed that the A allele decreased the production and activity of FAAH in humans [6].

AA=half FAAH enzymatic activity [7], reduced FAAH production, increased degradation of the enzyme, and less cellular stability [1].

These factors negatively impact FAAH, which increases anandamide (FAAH breaks anandamide down).

The Good

People with the A allele are less anxious and are thus less inclined to like marijuana.

They actually experience a decrease in happiness when smoking marijuana, compared with those with the normal FAAH gene, who find it pleasurable. If you naturally have more of the real thing you understandably have little use for marijuana [8].

Studies show that those with CC suffer more severe withdrawal when they stop using cannabis [8].

For example, one community-based study of almost 2,100 healthy volunteers found that people with AA had roughly half the rate (11 percent) of cannabis dependence than those one or more C’s (26 percent) [8].

Both mice and humans with the A allele showed enhanced fear extinction (they learned more efficiently how to be unafraid) [8].

AA is calmer/less anxious, has lower enzyme activity, higher anandamide, enjoys pot less, less likely to get addicted to pot, does better with extinction therapy in PTSD [8].

A has decreased threat-related amygdala reactivity and increased reward-related reactivity in the ventral striatum indicating its role in stress adaptation [9].

When mice were genetically engineered to have the AA version of the gene, they were less anxious. The mice showed similar changes in the neural circuits involved in people with lower anxiety and fear (greater connectivity between the prefrontal cortex and the amygdala).

A is less likely to develop cannabis dependence.

In some studies (but not all), A is associated with obesity [6].

The Bad

AA is at higher risk for substance abuse. AC is the normal risk [5]. A has a synergistic effect on these conditions with the CB1 receptor gene [10].

In a study of 80 people and 1,000 controls, AA was 5X more likely to abuse drugs (p = 0.00003) [11, 12].

AA and AC have a higher rate of anorexia [10].

One study found the exact opposite effect if some studies above and showed increased startle reaction in A carriers to unpleasant images [1].

Similarly, genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma. Specifically, the A allele is a risk factor for these conditions when exposed to childhood trauma [13].

The A allele was associated with lower HDL levels [4]:

  • CC=40.5
  • AC=39.1
  • AA=34.8

Each 1 mg/dl reduction in circulating HDL level is known to be associated with a 6% increase in the risk for cardiovascular disease [4].

Diet Interactions

In 451 obese Europeans undergoing a 6 week trial of a low-fat diet, subjects with AA experienced greater reductions in circulating triglycerides and total cholesterol levels) [14].

After weight loss, CC had an improvement on insulin and insulin resistance scores with an enriched monounsaturated fat hypocaloric diet [15].

People with an A allele lost less weight on this enriched monounsaturated fat hypocaloric diet. People with an A lost only 2.7 kg fat mass (CC lost 3.4 kg) [15].

Drug Interactions

A psychoactive ingredient in cannabis helped people with IBS-C more when they had CC [16].

The A allele is associated with antipsychotic-induced weight gain [17].


G is the more common allele. 35% of the alleles in the global population are “A”.


G=maybe higher FAAH activity [18].

Associations With The G Allele

The presence of the G allele was linked with an increase of recollections of the traumatic event [18].

G subjects showed more intense recollections of traumatic events and of negative childhood experiences [18].

In one study, rs2295633 was the only FAAH SNP to reveal a significant difference in PTSD prevalence. G compared with AA subjects, presented with a higher PTSD diagnosis prevalence (P=0.001) [18].

Negative early experiences increased PTSD risk only in those subjects presenting at least one G [18].

The G allele could serve as a possible marker for increased PTSD risk in subjects exposed to brain injury and combat experiences [18].

GG=higher arousal and lower fatigue levels after amphetamine ingestion [18].

Increased arousal has been linked with reduced FAAH activity in animal models, thus suggesting possible higher FAAH activity in G allele carriers [18].


G=possibly higher FAAH.

GG=higher Arousal levels (lower fatigue) after amphetamine ingestion [18].

Increased arousal has been linked with reduced FAAH activity in animal models, thus suggesting possible higher FAAH activity in G allele carriers [18].

How to Increase Cannabinoids

Stress Reduction

Prolonged exposure to elevated glucocorticoids (cortisol), such as those induced by chronic stress conditions, significantly reduces hippocampal CB1 receptors [9], leading to lower cannabinoid function.

In fact, a recent study suggests that CB1 receptor deficiency may mimic the effects of chronic stress on emotional behavior [9].

Omega 6’s

Anandamide, 2-AG, 2-AGE, and other endogenous cannabinoids are derived from arachidonic acid [19].

Studies of piglets show that dietary levels of arachidonic acid and other essential fatty acids affect the levels of anandamide and other endocannabinoids in the brain [20]. High-fat diet feeding in mice increases levels of anandamide in the liver [21].


Exercise increases anandamide, which is our natural CB1 activator [22].

High-fat diet

A high-fat diet increases liver levels of the endocannabinoid anandamide (arachidonoyl ethanolamide) and increases CB1 receptors [23].

Nicotine or Galantamine

Activation of nicotinic receptors leads to increased cellular levels of calcium (Dani et al., 2001), which is known to stimulate release of endogenous cannabinoids such as anandamide (Piomelli, 2003) [24].

Fish oil/DHA

DHA increases cannabinoid synthesis and CB1 and CB2 receptors [25].


Testosterone and DHT increase the CB1 receptors [26].


Estradiol increases anandamide and inhibits FAAH [27, 28], but it increases FAAH production [29].


Tea/EGCG (Full agonist, Ki 33.6 μM) [30, 31] – according to another group, flavonoid-type compounds (catechins, anthocyanidins, flavones) lead to negligible or very high Ki values, which likely reflect a nonspecific molecular denaturation of the protein surface rather than a functional binding interaction [32]


THC/Marijuana – potent CB1 activator [33]

CBD oil (increases CB1 receptors) [34]

Oleamide [35]

AspirinCOX-2 inhibitors activate the CB1 receptor [36]

Tylenol [37]

Palmitoylethanolamide – enhances anandamide [38]


Echinacea binds to the CB2 receptor [39]

Genistein [32]

Chocolate – N-acylethanolamines (NAEs), N-linoleoylethanolamide and N-oleoylethanolamine inhibit FAAH [32]

Beta-caryophyllene – activates CB2 receptor [32]

Kava/yangonin [40]

Kaempferol, 7-hydroxyflavone and 3,7-dihydroxyflavone have been shown to concentration-dependently inhibit anandamide hydrolysis in rat brain homogenates, albeit at relatively high concentrations (IC50 values between 2 and 10 mM). Nevertheless, the authors of these studies showed a preliminary structure-activity relationship with 7-hydroxyflavone (7-hydroxyflavone and 3,7-dihydroxyflavone have been shown to concentration-dependently inhibit anandamide hydrolysis in rat brain homogenates, albeit at relatively high concentrations (IC50 values between 2 and 10 mM). Nevertheless, the authors of these studies showed a preliminary structure-activity relationship with 7-hydroxyflavone [32].

Caffeine can help with a stress-induced decrease in the CB1 receptor [41].

Benzodiazepines work in part through CB1 receptors [42, 1].

About the Author

Joe Cohen, BS

Joe Cohen, BS

Joe Cohen flipped the script on conventional and alternative medicine…and it worked. Growing up, he suffered from inflammation, brain fog, fatigue, digestive problems, insomnia, anxiety, and other issues that were poorly understood in traditional healthcare. Frustrated by the lack of good information and tools, Joe decided to embark on a learning journey to decode his DNA and track his biomarkers in search of better health. Through this personalized approach, he discovered his genetic weaknesses and was able to optimize his health 10X better than he ever thought was possible. Based on his own health success, he went on to found SelfDecode, the world’s first direct-to-consumer DNA analyzer & precision health tool that utilizes AI-driven polygenic risk scoring to produce accurate insights and health recommendations. Today, SelfDecode has helped over 100,000 people understand how to get healthier using their DNA and labs.
Joe is a thriving entrepreneur, with a mission of empowering people to take advantage of the precision health revolution and uncover insights from their DNA and biomarkers so that we can all feel great all of the time.


1 Star2 Stars3 Stars4 Stars5 Stars
(4 votes, average: 5.00 out of 5)

FDA Compliance

The information on this website has not been evaluated by the Food & Drug Administration or any other medical body. We do not aim to diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles View All